Skip to main content

New Jersey Finally Passes Cannabis Legalization Implementation Legislation

The road to adult-use cannabis legalization in New Jersey has been a long, winding path riddled with hurdles and setbacks. After New Jersey failed to legalize cannabis via the legislative process for many years lawmakers referred the issue to voters.

Voters approved the cannabis legalization measure in a resounding fashion during the 2020 general election. While the vote legalized cannabis in New Jersey, implementation legislation was still required.

After a lot of back and forth, New Jersey lawmakers finally passed the necessary legislation and Governor Phil Murphy has signed it. Below is more information about it via a news release from our friends at NORML:

Democratic Governor Phil Murphy signed enabling legislation into law on Monday realizing voters’ Election Day demands to legalize adult-use marijuana possession and license retail marijuana sales.

Three bills were signed by the Governor. A21/S21 licenses the commercial production and retail sale of cannabis to adults. Under the new law, those age 21 or older may legally purchase and possess up to one ounce of cannabis. Retail sales are subject to state sales tax. Seventy percent of the revenue derived from sales taxes will be directed toward reinvestment in designated, lower-income communities. An additional excise tax will also be imposed on commercial sales.

The new law caps the number of state-licensed cultivators at 37 for the first two years. Existing state-licensed medical cannabis producers will be among those eligible to provide to the retail market. It has been estimated that adult-use retailers may be operational within six months.

Murphy also signed A1897, which removes criminal and civil penalties for the private possession of up to six ounces of cannabis by adults, as well as for the possession of personal use amounts of hashish (up to 170 grams). It also depenalizes activities involving the transfer of up to one ounce of cannabis, and reduces criminal penalties for activities involving larger quantities (distribution of more than one ounce, but less than five pounds) of the substance.

Provisions in the law also seek to facilitate the expungement of criminal records involving low-level marijuana crimes. Said Gov. Murphy in a statement, “Starting immediately, those who had been subject to an arrest for petty marijuana possession will be able to get relief and move forward.”

Gov. Murphy also signed a third piece of legislation into law, A5342. It provides for a series of written warnings, rather than the imposition of either criminal penalties or fines, for those under the age of 21 who are caught with cannabis. The Governor lobbied for the measure, which was passed by lawmakers just hours before being signed into law. Under the measure, third-time juvenile offenders could receive community service. Provisions in the law also restrict police from conducting searches of juveniles based solely on the odor of marijuana and include punitive measures if law enforcement intentionally do so anyway.

“The enactment of these laws is long overdue,” said NORML State Policies Manager Carly Wolf — who emphasized that state and local police have made over 6,000 arrests for marijuana-related violations in the months since New Jersey voters overwhelmingly decided in favor of legalization at the ballot box. Newly issued guidance from the state’s attorney general’s office has requested that local prosecutors drop those cases. “Now, going forward, tens of thousands of otherwise law-abiding New Jerseyans will no longer be subject to arrest and a criminal record for their personal use of marijuana, and the commercial market will be regulated in a fair and inclusive manner.”

An analysis of nationwide arrest data published in 2018 reported that New Jersey ranked third in the nation in total marijuana arrests and second only to Wyoming in per capita arrests.

Provisions in the bill allowing the use and possession of marijuana take immediate effect.

“While we are pleased to see the will of New Jersey voters finally enshrined into approved legislation, it was a grotesque failure on the part of elected leadership that it took so long to do so,” stated NORML Executive Director Erik Altieri, “Despite nearly seven in ten New Jersey residents voting in favor of legalization on Election Day, it took lawmakers 111 days following that vote to achieve consensus to enact enabling legislation into law. During this undue delay, over 6,000 citizens faced charges for activities most New Jerseyans demanded be legalized. It is our hope that lawmakers and regulators going forward implement these laws with a renewed sense of urgency.”

Governor Murphy acknowledged the delay, stating, “Although this process has taken longer than anticipated, I believe it is ending in the right place and will ultimately serve as a national model.”

New Jersey is among the fifteen states where either voters or lawmakers have enacted legislation legalizing the possession and distribution of marijuana to adults.

 

A French Lawmaker Suggests Cannabis Legalization Via Referendum

Momentum for adult-use cannabis legalization is building, with many countries on the European continent exploring the idea of reforming their cannabis policies to permit adult-use cannabis.

One country that seems to be moving in the right direction is France, which fairly recently updated its cannabis policy to issue fines instead of jail time for personal cannabis possession.

Personal cannabis possession now results in a 200 euro fine instead of the previous penalty of up to a year in jail and a 3,750 euro fine.

Adult-use cannabis legalization faces an uphill battle in France, however, a freshly proposed idea could gain traction. Per LCI:

Will the French be led to decide one day, by referendum, the burning question of recreational cannabis? In any case, this is a hypothesis formulated on Sunday February 28 by the deputy LaREM of the Creuse Jean-Baptiste Moreau, rapporteur for an information mission on the subject.

“We will have to launch a real popular consultation and why not a referendum,” said the latter, this Sunday on France Info. Supporter of legalization to regulate the consumption of cannabis, especially among young people, the deputy believes “that we really need a debate to enlighten citizens on this topic” . “Today, we are facing a ban, but a record consumption. So the situation is not sustainable.” 

As alluded to by the lawmaker that proposed the referendum approach, France is experiencing record-levels for cannabis consumption. Consumptions levels in France are greater than in any other European nation.

Cannabis decriminalization is obviously better than locking people up for cannabis, however, it’s not nearly enough. France needs to get on the right side of history and legalize cannabis for adult-use and let the legal cannabis industry reach its full potential.

Letting voters decide would all but guarantee that France approves cannabis legalization depending on the specific provisions of the measure being proposed. Hopefully voters get that chance.

Portuguese Authorities Set Retail Price For Medical Cannabis

Infarmed, the Portuguese medicines and medical devices agency, has now set a reference retail price for medical cannabis patients in pharmacies that equals the black-market price – but still no word on whether health insurers will reimburse the costs.

Portuguese patients can look forward to a more regulated retail price for medical cannabis at pharmacies as of April this year. Infarmed, the Portuguese version of the FDA, has set the price for 15-gram bags of medical cannabis at the point of sale in pharmacies at €150 per bag of 18% THC flower. This means that retail prices for cannabis in pharmacies is now set at widely set black market rates across Europe.

This price point is also roughly equivalent to what insurers are reimbursing pharmacies for in Germany – which begins to create a regional, not just in-country reference price for the industry.

The next problem is, however, is that unlike Germany, the list of conditions the drug will be prescribed for is much narrower than in Deutschland (basically six conditions commonly seen in MS, cancer, AIDS and chronic pain). Further, there is no discussion (yet) as to whether national health will cover the cost (as is true in Germany, even if it is still a major bureaucratic, paper strewn fight). In Germany, those patients who are able to obtain coverage face a bill of €12 a month.

How Will This Help the Overall Legalization Discussion?

While the formal price setting is certainly a good step, and further one which takes real market conditions into consideration, a terrible price gap is still in the room for the most vulnerable of patients – in other words, precisely the people who are likely to get a prescription in the first place. Three hundred euros a month is about the amount of disposable cash a person on disability benefits gets to spend every month on food and other essentials. There is no way such people can afford the new “legal” channel of cannabis unless they get some kind of additional help.

Regardless of the immediate impact on the ground in Portugal however, this is a clear sign that the commercial medical market is in fact beginning to normalize – not only in country but across the region.

This also means that GMP producers, for example, can begin to have a much clearer idea of returns, costs and margin throughout the supply chain. This in turn will have a stabilizing impact on the industry – and allow investors to have a much better idea of potential returns.

As a result? 2021 and beyond should begin to see the kind of serious investment in the infrastructure of the industry that it actually needs. And that is good news for everyone.

Be sure to book your tickets now for the upcoming investment and business networking International Cannabis Business Conference in Austin and Berlin!

Morocco: The Next Country Cannabis Domino To Fall

A bill to legalize medical cannabis is widely expected to pass in Morocco this week after multiple previous attempts at reform have failed

As Reuters reported last weekend, the African country of Morocco plans to pass a bill this week to allow for the farming, export and domestic sale of cannabis for medical and industrial use.

The idea is to use such revenue to help impoverished farmers in the Rif mountains. 

Although this legislation will finally legalize cannabis in the country, Morocco is no stranger to the cannabis plant. Indeed, the country has been one of the top global producers of the illicit variety according to the UN. In December, Morocco was one of the countries to vote for the removal of cannabis from Schedule IV classification internationally.

The Impact on Europe

The change in this North African country’s drug policies could have potentially huge knock-on effects in several places, starting with Europe – and not just in helping to stem the illicit cannabis and hash flows north into the region from Morocco. Legalization of the cultivation and trade routes will do much to clean up corruption and the violent black market that has long also been associated with the same.

However, what it will also do is introduce a huge potential source of at least raw cannabis that can then be processed in Europe, even if it is not grown there. If not introduce 

The implications as a result, both for the medical market as well as the industrial one is large.

Cannabis as High-Value Cash Crop

As countries in Europe continue to set official prices along the supply chain (see most recently Portugal’s point of sale medical pricing), it means that the hunt for high-quality cannabis at price points that can only be created with less than Northern European labour rates will rev up to a new urgency. Particularly as countries like Germany also begin to establish in-country extraction facilities.

Even so, cannabis is certainly likely to remain a cash crop with a premium that beats most other kinds of agriculture. For that reason, poor farmers everywhere, including places like Morocco, stand to benefit.

While growing cannabis legally of course is not a panacea, anywhere, for embedded social and economic problems, creating legitimate cultivation markets for it is also proving to be good for starting to address some of them.

Be sure to book your tickets now for the upcoming International Cannabis Business Conference events in Austin Texas and Berlin Germany!

A Cannabis Rift Between Bermuda And The UK

It is no secret that the ongoing COVID pandemic has had a detrimental impact on the world’s economy. Many industries are struggling and countless businesses have had to close either temporarily or permanently.

As the international community looks towards a post-pandemic global economy, one industry is poised to come out far stronger after the pandemic than before the pandemic started – the cannabis industry.

The global cannabis industry is booming by virtually every standard and measurement right now, and once the global economy opens back up the cannabis industry is likely to experience further growth.

It’s one of the very few industries that possess the ability to successfully operate in virtually every country and region, provided that the cannabis industry is afforded the legal opportunity to do so.

One country that is ramping up its cannabis industry is Bermuda, although pushback from the United Kingdom is making thing tense between the two countries. Per Royal Gazette:

The Premier said last night Bermuda’s relationship with the UK would suffer serious damage if a law to license cannabis production failed to get Royal Assent.

David Burt said there were indications that the Governor would be unable to give assent to legislation that contravened Britain’s international obligations.

But he added: “This legislation will pass … If Her Majesty’s representative in Bermuda does not give assent to something that has been passed lawfully and legally under this local government, this will destroy the relationship that we have with the United Kingdom.”

Just because the United Kingdom’s current cannabis policy is terrible does not mean that patients in other countries should suffer too. Bermuda is doing the right thing by not letting the UK bully them around.

It’s guaranteed that if Royal Assent is not granted, and Bermuda pursues licensed cannabis production anyways, that the sky will still remain intact and that the posturing out of the UK will prove to just be reefer madness bluffing.

The UK is clearly on the wrong side of history and has been for far too long when it comes to cannabis policy.

Thailand To Include Cannabis On Essential Drugs List

Thailand is rapidly becoming an international leader when it comes to cannabis policy. In 2018 Thailand legalized hemp and CBD products, and then expanded its law in 2019 to help more patients.

When it legalized medical cannabis, Thailand became the first country in the entire region to do so, and while other countries in the region have been slow to reform their own laws, reform in Thailand has certainly provided a boost to momentum for further reform in South-East Asia.

The government in Thailand recently announced yet another reform, which will involve adding cannabis to the nation’s ‘essential drugs’ list. Per Bangkok Post:

The Food and Drug Administration (FDA) is pushing to expedite the listing of cannabis in the National List of Essential Medicines, a move intended to ensure its availability to those who need it, Public Health Minister Anutin Charnvirakul said on Monday.

Speaking at the official opening of the Institute of Medical Cannabis, Mr Anutin said since the Public Health Ministry approved the use of cannabis and hemp for medical and research purposes, more than 50,000 patients have been prescribed cannabis-based treatments by licenced health professionals.

Whereas cannabis remains on many controlled substances lists around the globe that prohibits its use, Thailand is embracing the cannabis plant as a medicine and that is something that other countries will hopefully emulate.

Adding cannabis to the essential drugs list is the latest move by Thailand to encourage the cultivation and use of medical cannabis by its citizens, and to further promote cannabis as the country’s next big cash crop.

“So far, 2,500 households and 251 provincial hospitals have grown 15,000 cannabis plants,” deputy government spokeswoman Traisulee Traisoranakul recently said according to Bangkok Post. “We hope that cannabis and hemp will be a primary cash crop for farmers.”

The Swiss Step Carefully Into First Semi-Legalization Project

Recreational cannabis will be available from Swiss pharmacies as of 2022, on a limited trial basis.

If there is one word to describe the European approach to cannabis generally, it has been so far, caution. If there was another, it would be regulation. There is nothing “casual” or indeterminate in every European national approach to a conversation that is now so overdue it is burning its way into international discourse.

Even more pressing for the Swiss at this point, a non-EU nation in the middle of Europe, is the fact that their neighbours in Luxembourg are barrelling towards a recreational experiment of their own in 2022.

The solution? A national trial which will allow up to 5,000 adults per participating municipality, to purchase cannabis in Swiss pharmacies – without a prescription. Even more intriguingly, all the cannabis sold via this route must be produced domestically (it cannot be imported). Furthermore, THC content may not exceed 20%.

Prices will be set to compete with the black market – and can be adjusted on the level of THC in the strain.

Cities must submit their own plans to participate in the trial, which is intended to run for five years.

Some of the other requirements are a bit vague including proving “previous experience” with the plant as a consumer. How is one supposed to “prove” a previous experience with cannabis? No doubt the savvy Swiss will find a way.

It may not be Colorado, in other words. But it is clearly a move in the right direction. And further, it may also signal where Luxembourg’s first recreational cannabis crops will come from beyond Portugal.

A Blended Market Based on High Levels of Testing

For all the lack of opportunity – at the moment – for a “coffee shop culture” there is one thing to say about the Swiss experiment. It will be regulated, from the beginning with high levels of testing along the way. GMP levels may not be required for cultivation but testing in GMP labs is likely to become de rigeur. In Switzerland, as well as across Europe. 

There are unlikely to be as a result, any pesticide scandals rocking the nascent Swiss recreational industry.

How this hybrid approach will work is still, for the moment, in the hands of cities across Switzerland who are now tasked with coming up with detailed plans. Will it all go as smoothly as a proverbial Swiss watch? Undoubtedly not. This is cannabis reform after all. But it is a venture into territory which for the most part, most European countries are still highly loath to tread.

For the most updated information on the changing regulations of the European cannabis industry, be sure to book your tickets to the International Cannabis Business Conference when it returns to Europe, Summer of 2021.

Bangkok Embraces Cannabis Cafe Culture

It may not be Amsterdam, but Thailand is taking a stab at infused cannabis reform.

Thailand, which enacted cannabis reform as of Christmas Day, 2018, as a “gift” to the Thai people, has slowly begun to define a domestic cannabis culture. This, also despite the rigors of the Covid-19 Pandemic, includes retail establishments like cafes and restaurants that are reaching into traditional cuisine and culture to create a host of CBD-infused delicacies, from teas to food infusions.

On December 9, 2020, most of the cannabis plant, except for THC-rich flowers, has been decriminalized formally for commercial, licensed purposes. The Health Ministry is still responsible for dispensing these.

The first “cannabis cafe” has now even opened in the Thai capital, serving products sourced from an authorized local farm. 

They also have competition from another establishment – a dessert shop that plans to sell sweets infused with cannabis.

However, Bangkok is not the only city to see cannabis cuisine pop up in the country. In Prachinburi province, a new cafe and restaurant began offering cannabis-infused dishes, including deep-fried cannabis leaves and pizza.

This entrepreneurial boost is, of course, notably happening during COVID-19. When travel opens again, Thailand is sure to be ready for them, with its new cannabis offerings.

Cannabis Tourism After COVID-19

The Thai embrace of the regulated industry, albeit without the THC, is in marked contrast to the Dutch take on the same – notably in the city of Amsterdam. Pot tourism, generally, is not popular right now in Europe, in direct contrast to say, Thai efforts. 

What will happen in the aftermath of COVID-19, however, is very much in the air. In multiple jurisdictions, access to the drug has noticeably shrunk thanks to Pandemic-related measures. It is unlikely to stay stuffed in this box as restrictions lift.

This is especially true in Europe right now – where the Dutch recreational tender is still unresolved, and as Luxembourg eyes its own on-ramp to the discussion, now scheduled for the end of this year if not early next.

There is also, of course, Greece, which has hovered over the discussion for the last several years as the country continues to try to rebuild its own economy, which already cannot be entirely disentangled from at least the medical cannabis conversation.

Post–andemic, the discussion of retail establishments operating legitimately in the biz, whether they are geared to a local or visiting audience is going to be hot stuff.

Be sure to book your tickets now to the International Cannabis Business Conference when it returns to Berlin, Summer 2021.

Spanish Government Continues To Fund Medical Cannabis Research Even As It Has Jailed Club Activist

Despite the red tape and the imprisonment of Albert Tio the Spanish government is funding some medical cannabis research

Some good news from Spain on the cannabis front at last! As reported by Público, a Spanish-language public affairs and news zine, the Botanical Institute of Barcelona which is a joint project of the Higher Council for Scientific Research (CSIC) and the City Council of the Catalan capital is entering its fourth year of government funding for cannabis research.

The project is funded on a federal level by the Ministry of Science and Innovation, which has been given a license by the Spanish Agency for Medicines and Medical Devices (AEMPS). The ultimate objective of the study is to understand the plant’s traditional uses in human history.

The project, led by Teresa Garnatje, consists of 12 researchers and the faculty of Food Sciences of the University of Barcelona. Researchers have already traveled to several countries to obtain, in collaboration with local botanists, samples of indigenous, or what is called “Landrace” cannabis strains. They are also actively asking that those in countries where cannabis is not legal or other restrictions on travel and research exist, that they at least obtain samples of DNA. So far, the team has been focused on Asia and Eastern Europe where cannabis is more easily found still in the wild and uncultivated.

Three years into the project, the researchers have so far gathered between 5-600 samples. The idea is to understand the genetic components of the plant, the variability of species found in the wild, and a way to improve production – whether by growing in “natural” environments or even hybridized.

Given how unstable commercial strains of the plant have proved to be, especially in a GMP, pharmacized production environment, this research may help improve production quality and stability in every medical cultivation market.

However, the question also remains at this point, with a human rights claim pending in Strasbourg, how the Spanish government can jail an activist whose only crime was being ahead of the formal research and putting his life on the line for better access for those who need the drug the most.

This kind of hypocrisy is nothing new of course – in Spain or anywhere else reform powers forward. But is the reason why full and final reform is needed, now. In Spain. In Europe. Not to mention many other regions and jurisdictions.

Be sure to book your tickets for the International Cannabis Business Conference when it returns to Berlin this summer!